Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Trimoreau, F' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 38 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Francois, B; Trimoreau, F; Desachy, A; Besse, A; Rangez, S; Praloran, V; Vignon, P
      Haemophagocytosis during multiple organ failure: M-CSF overproduction or viral reactivation?

      ANNALES FRANCAISES D ANESTHESIE ET DE REANIMATION
    2. Chaperot, L; Bendriss, N; Manches, O; Gressin, R; Maynadie, M; Trimoreau, F; Orfeuvre, H; Corront, B; Feuillard, J; Sotto, JJ; Bensa, JC; Briere, F; Plumas, J; Jacob, MC
      Identification of a leukemic counterpart of the plasmacytoid dendritic cells

      BLOOD
    3. Denizot, Y; Raher, S; Trimoreau, F; Praloran, V; Godard, A
      Effect of cytokines and lipid mediators on the synthesis of interleukin 1 beta by human bone marrow stromal cells

      CYTOKINE
    4. Besse, A; Trimoreau, F; Praloran, V; Denizot, Y
      Effect of cytokines and growth factors on the macrophage colony-stimulating factor secretion by human bone marrow stromal cells

      CYTOKINE
    5. Trimoreau, F; Francois, B; Desachy, A; Besse, A; Vignon, P; Denizot, Y
      Platelet-activating factor acetylhydrolase and haemophagocytosis in the sepsis syndrome

      MEDIATORS OF INFLAMMATION
    6. Ivanovic, Z; Dello Sbarba, P; Trimoreau, F; Faucher, JL; Praloran, V
      Primitive human HPCs are better maintained and expanded in vitro at 1 percent oxygen than at 20 percent

      TRANSFUSION
    7. Denizot, Y; Godard, A; Raher, S; Trimoreau, F; Praloran, V
      Lipid mediators modulate the synthesis of interleukin 8 by human bone marrow stromal cells

      CYTOKINE
    8. Denizot, Y; Turlure, P; Bordessoule, D; Trimoreau, F; Praloran, V
      Serum IL-10 and IL-13 concentrations in patients with haematological malignancies

      CYTOKINE
    9. Denizot, Y; Desplat, V; Dulery, C; Trimoreau, F; Praloran, V
      Arachidonic acid and freshly isolated human bone marrow mononuclear cells

      MEDIATORS OF INFLAMMATION
    10. Besse, A; Trimoreau, F; Faucher, JL; Praloran, V; Denizot, Y
      Prostaglandin E-2 regulates macrophage colony stimulating factor secretionby human bone marrow stromal cells

      BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
    11. Denizot, Y; Besse, A; Raher, S; Nachat, R; Trimoreau, F; Praloran, V; Godard, A
      Interleukin-4 (IL-4), but not IL-10, regulates the synthesis of IL-6, IL-8and leukemia inhibitory factor by human bone marrow stromal cells

      BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
    12. Desplat, V; Petit, B; Trimoreau, F; Praloran, V; Denizot, Y
      EP2 and EP4 receptor subtypes in human bone marrow stromal cells

      BRITISH JOURNAL OF HAEMATOLOGY
    13. TRIMOREAU F; GACHARD N; JACCARD A; TONI FB; BORDESSOULE D; PRALORAN V
      B-CELL COMPARTMENTS IN MULTIPLE-MYELOMA - FLOW CYTOMETRIC ANALYSIS OFTHEIR LABELING INDEXES AND BCL-2 PROTEIN EXPRESSION

      HEMATOLOGY AND CELL THERAPY
    14. DENIZOT Y; TRIMOREAU F; PRALORAN V
      EFFECTS OF LIPID MEDIATORS ON THE SYNTHESIS OF LEUKEMIA INHIBITORY FACTOR AND INTERLEUKIN-6 BY HUMAN BONE-MARROW STROMAL CELLS

      Cytokine (Philadelphia, Pa. Print)
    15. DESPLAT V; DUPUIS F; TRIMOREAU F; DULERY C; PRALORAN V; DENIZOT Y
      EFFECTS OF LIPOXYGENASE METABOLITES OF ARACHIDONIC-ACID ON THE GROWTHOF HUMAN MONONUCLEAR MARROW-CELLS AND MARROW STROMAL CELL-CULTURES

      Mediators of inflammation
    16. FRANCOIS B; CLAVEL M; TRIMOREAU F; DESACHY A; SLAOUTI P; GASTINNE H
      PANCYTOPENIA AND PULMONARY TUBERCULOSIS - THE SIGNIFICANCE OF A HEMOPHAGOCYTIC SYNDROME

      Revue des maladies respiratoires
    17. DENIZOT Y; DULERY C; TRIMOREAU F; DESPLAT V; PRALORAN V
      ARACHIDONIC-ACID AND HUMAN BONE-MARROW STROMAL CELLS

      Biochimica et biophysica acta. Molecular cell research
    18. Avet-Loiseau, H; Li, JY; Facon, T; Brigaudeau, C; Morineau, N; Maloisel, F; Rapp, MJ; Talmant, P; Trimoreau, F; Jaccard, A; Harousseau, JL; Bataille, R
      High incidence of translocations t(11;14)(q13;q32) and t(4;14)(p16;q32) inpatients with plasma cell malignancies

      CANCER RESEARCH
    19. JACCARD A; TOUATI M; SOL C; BORDESSOULE D; COUTY JP; ROGEZ S; TRIMOREAU F
      HUMAN-HERPESVIRUS-8 AND RELATIVES OF PATIENTS WITH PLASMACYTIC DISEASES

      Blood
    20. LIOZON E; BRIGAUDEAU C; TRIMOREAU F; DESANGLES F; FERMEAUX V; PRALORAN V; BORDESSOULE D
      IS TREATMENT WITH HYDROXYUREA LEUKEMOGENIC IN PATIENTS WITH ESSENTIALTHROMBOCYTHEMIA - AN ANALYSIS OF 3 NEW CASES OF LEUKEMIC TRANSFORMATION AND REVIEW OF THE LITERATURE

      HEMATOLOGY AND CELL THERAPY
    21. LORGEOT V; TRIMOREAU F; GACHARD N; PRALORAN V; DENIZOT Y
      LEUKEMIA INHIBITORY FACTOR CONCENTRATIONS IN THE BONE-MARROW PLASMA OF HEALTHY-SUBJECTS AND PATIENTS WITH HEMATOLOGIC MALIGNANCIES

      European cytokine network
    22. MAYNADIE M; CAMPOS L; MOSKOVTCHENKO P; SABIDO O; AHO S; LENORMAND B; CARLI PM; GUYOTAT D; BENE MC; FAURE G; CAPIOD JC; GARDAIS J; FEUILLARD J; RAPHAEL M; LACOMBE R; LECALVEZ G; LEGLISE MC; DENEYS V; MASSON AM; BERNIER M; MALET AM; SALAUN C; BOURIN P; RAPATEL C; TAVERNIER F; JOUAULT H; LELONG F; CHRETIEN P; SOLARY E; CASASNOVAS RO; MAYNADIE M; MOSKOVTCHENKO P; FAVRE M; BENSA JC; JACOB MC; WALLEF G; SARIAUX C; TRIMOREAU F; PRALORAN V; CAMPOS L; SABIDO O; VASSELON C; BRUNET C; PONCELET P; GUITARD AM; TAIB J; LAVABREBERTRAND T; JUNG G; KANDEL G; GARAND R; PHILIP P; SUDAKA I; MONPOUX F; VANHAEKE D; PERROT JY; MARIE JP; VALENSI F; VERGE V; HOMBERG JC; SCHAISON G; BOUMSELL L; DOUAY L; SAMSON T; BRIZARD A; DALIPHARD S; DRENOU B; LEES O; LENORMAND B; POILANE B; FALKENRODT A; ALBERT A; KUHLEIN E; ESTIENNE MH; BREMOND JL; DEGENNE M; LEBARON F; REUMAUX G; DUTHILLEUL P; BENE MC; FAURE G; BORDIGONI P; WITZ F; KOLLOPSARDA MN; BAYLE C; ANTONINI J; BOUCHEIX C; CHARPENTIER A
      HETEROGENOUS EXPRESSION OF CD15 IN ACUTE LYMPHOBLASTIC-LEUKEMIA - A STUDY OF 10 ANTI-CD15 MONOCLONAL-ANTIBODIES IN 158 PATIENTS

      Leukemia & lymphoma
    23. DENIZOT Y; ROUGIER F; DUPUIS F; TRIMOREAU F; DULERY C; LASKAR M; PRALORAN V
      PRESENCE AND METABOLISM OF LYSO-PLATELET-ACTIVATING-FACTOR IN HUMAN BONE-MARROW

      Journal of lipid mediators and cell signalling
    24. DUPUIS F; ROUGIER F; TRIMOREAU F; OSTYN E; DULERY C; PRALORAN V; DENIZOT Y
      PRODUCTION AND METABOLISM OF PLATELET-ACTIVATING-FACTOR BY HUMAN BONE-MARROW CELLS

      Research in immunology
    25. TRIMOREAU F; VERGER C; PRALORAN V; DENIZOT Y
      NO SEX-RELATED DIFFERENCE IN THE MYELOID ERYTHROID RATIO IN MORPHOLOGICALLY NORMAL BONE-MARROW ASPIRATES/

      British Journal of Haematology
    26. BRIGAUDEAU C; TRIMOREAU F; GACHARD N; ROUZIER E; JACCARD A; BORDESSOULE D; PRALORAN V
      CYTOGENETIC STUDY OF 30 PATIENTS WITH MULTIPLE-MYELOMA - COMPARISON OF 3 AND 6 DAY BONE-MARROW CULTURES STIMULATED OR NOT WITH CYTOKINES BYUSING A MINIATURIZED KARYOTYPIC METHOD

      British Journal of Haematology
    27. FRANCOIS B; TRIMOREAU F; VIGNON P; FIXE P; PRALORAN V; GASTINNE H
      THROMBOCYTOPENIA IN THE SEPSIS SYNDROME - ROLE OF HEMOPHAGOCYTOSIS AND MACROPHAGE-COLONY-STIMULATING FACTOR

      The American journal of medicine
    28. DENIZOT Y; FIXE P; TRIMOREAU F; PRALORAN V
      MACROPHAGE-COLONY-STIMULATING FACTOR LEVELS IN THE PLASMA OF BONE-MARROW ASPIRATE IN SEVERAL HEMATOLOGICAL MALIGNANCIES

      Stem cells
    29. DENIZOT Y; DUPUIS F; TRIMOREAU F; VERGER C; ALLEGRAUD A; PRALORAN V
      PAF AND HEMATOPOIESIS .4. PLATELET-ACTIVATING-FACTOR INCREASES DNA-SYNTHESIS IN HUMAN BONE-MARROW CELLS

      Journal of lipid mediators and cell signalling
    30. BRIGAUDEAU C; LIOZON E; BERNARD P; TRIMOREAU F; BORDESSOULE D; PRALORAN V
      DELETION OF CHROMOSOME 20Q ASSOCIATED WITH HYPEREOSINOPHILIC SYNDROME- A REPORT OF 2 CASES

      Cancer genetics and cytogenetics
    31. VANHAEKE DR; BENE MC; GARAND R; FAURE GC; GARDAIS J; LEGLISE MC; LECALVEZ G; BERNIER M; MASSY M; GRIVEAU AM; BROUTARD P; LEBRUN C; BONHOMME J; CHASSAGNE B; DEMEOCQ F; RAPATEL C; TAVERNIER F; JOUAULT H; LELONG F; CHRETIEN P; SOLARY E; CASASNOVAS RO; MAYNADIE M; BENSA JC; FAVRE M; JACOB MC; SARTIAUX C; HUART JL; DROUET M; PRALORAN V; TRIMOREAU F; CAMPOS L; LARESE A; PONCELET P; BESSONFAURE I; BRUNET C; LAVABREBERTRAND T; TAIB J; KANDEL G; JUNG G; HARROUSSEAU JL; PHILIP P; MONPOUX F; BAUDOUIN F; SUDAKA I; CALDANI C; VANHAEKE D; BERNARD A; VALENSI F; BOURIN P; ARBORIO M; SCHAISON G; BOUMSELL L; ADAM M; DOUAI L; BRIZARD A; DALIPHARD S; GENETET N; FAUCHET R; DRENOU B; LEES O; LENORMAND B; VANNIER JP; SABIDO O; GUYOTAT D; VASSELON C; FALKENRODT A; ALBERT A; BREMOND JL; GEORGET MT; KUHLEIN E; LEBARON F; DUTHILLEUL P; REUMAUX F; FAURE G; KOLOPPSARDA MN; BORDIGONI P; WITZ F; BAYLE C; ANTONINI J; CHARPENTIER A
      EXPRESSION AND LONG-TERM PROGNOSTIC VALUE OF CD34 IN CHILDHOOD AND ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA

      Leukemia & lymphoma
    32. DENIZOT Y; TRIMOREAU F; DUPUIS F; VERGER C; PRALORAN V
      PLATELET-ACTIVATING-FACTOR CONCENTRATIONS IN BONE-MARROW OF PATIENTS WITH LYMPHOID AND NONLYMPHOID HEMATOLOGIC MALIGNANCIES

      Leukemia
    33. FRANCOIS B; TRIMOREAU F; VIGNON P; VERGER G; GASTINNE H
      REACTIVE HEMOPHAGOCYTIC SYNDROME - A PROB ABLY UNDERESTIMATED CAUSE OF THROMBOCYTOPENIA IN ICU PATIENTS

      Annales francaises d'anesthesie et de reanimation
    34. DENIZOT Y; TRIMOREAU F; DUPUIS F; VERGER C; PRALORAN V
      PAF AND HEMATOPOIESIS .3. PRESENCE AND METABOLISM OF PLATELET-ACTIVATING-FACTOR IN HUMAN BONE-MARROW

      Biochimica et biophysica acta. Molecular cell research
    35. LIOZON E; VOLKOV L; COMTE L; TRIMOREAU F; PRADELLES P; BORDESSOULE D; FRINDEL E; PRALORAN V
      ACSDKP SERUM CONCENTRATIONS VARY DURING CHEMOTHERAPY IN PATIENTS WITHACUTE MYELOID-LEUKEMIA

      British Journal of Haematology
    36. DENIZOT Y; DUPUIS F; TRIMOREAU F; PRALORAN V; LIOZON E
      DECREASED LEVELS OF PLATELET-ACTIVATING-FACTOR IN BLOOD OF PATIENTS WITH LYMPHOID AND NONLYMPHOID HEMATOLOGIC MALIGNANCIES

      Blood
    37. GARAND R; BENE MC; GARDAIS J; DUBOSCMARCHENAY N; LACOMBE F; LEGLISE MC; LECALVEZ G; BERNIER M; MASSY M; GRIVEAU AM; BROUTARD P; LEBRUN C; BONHOMME J; CHASSAGNE B; DEMEOCQ F; RAPATEL C; TAVERNIER F; JOUAULT H; LELONG F; SOLARY E; CASASNOVAS RO; MAYNADIE M; BENSA JC; FAVRE M; JACOB MC; SARTIAUX C; HUART JL; DROUET M; PRALORAN V; TRIMOREAU F; CAMPOS L; LARESE A; PONCELET P; BESSONFAURE I; BRUNET C; LAVABREBERTRAND TL; TAIB J; KANDEL G; JUNG G; HARROUSSEAU JL; PHILIP P; MONPOUX F; BAUDOUIN F; SUDAKA I; CALDANI C; POMIER G; BERNARD A; REGUER M; SCHILL H; BOURIN P; ARBORIO M; SCHAISON G; BOUMSELL L; ADAM M; DOUAI L; VANHAECKE D; BRIZARD A; ROUALET JP; TABARY T; CHAUMAREL I; GENETET N; FAUCHET R; DRENOU B; LEES O; LENORMAND B; VANNIER JP; LEPETIT JC; ACQUART S; SABIDO O; GUYOTAT D; VASSELON C; FALKENRODT A; ALBERT A; BREMOND JL; GEORGET MT; ROUBINET F; KUHLEIN E; LEBARON F; DUTHILLEUL P; REUMAUX F; FAURE G; KOLOPPSARDA MN; BORDIGONI P; WITZ F; BAYLE C; ANTONINI J; CHARPENTIER A
      A NEW APPROACH OF ACUTE LYMPHOBLASTIC-LEUKEMIA IMMUNOPHENOTYPIC CLASSIFICATION - 1984-1994 THE GEIL EXPERIENCE

      Leukemia & lymphoma
    38. LIOZON E; VOLKOV L; COMTE L; TRIMOREAU F; PRADELLES P; BORDESSOULE D; FRINDEL E; PRALORAN V
      VARIATIONS OF SERUM ACSDKP CONCENTRATIONS DURING INDUCTION CHEMOTHERAPY IN ACUTE MYELOID-LEUKEMIA (AML)

      Blood


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 27/05/20 alle ore 12:55:16